Clovis Oncology (CLVS) Misses Q4 EPS Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Clovis Oncology Announces 2015 Operating Results
February 25, 2016 4:05 PM ESTRociletinib NDA scheduled for discussion at ODAC panel on April 12 with a June 28 PDUFA date Rucaparib NDA submission for treatment of advanced ovarian cancer expected to complete Q2 2016
BOULDER, Colo.--(BUSINESS WIRE)-- Clovis Oncology, Inc. (NASDAQ: CLVS) reported financial results for its quarter and year ended... More
